What one share of Gilead Sciences holds
Gilead Sciences, Inc. (including its consolidated subsidiaries, referred to as “Gilead,” the “company,” “we,” “our” or “us”) is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.
Gilead Sciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $24.40 |
|---|---|
| Profit | −$2.60 |
| Capex (buildings and equipment) | $0.49 |
| Free cash flow | $10.37 |
| Dividends | $3.22 |
| Cash and investments | $2.56 |
| Debt | $21.15 |
| Book value | $9.53 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2007 | $2.19 | $0.82 | $0.04 | $0.82 | — | $2.02 |
| 2008 | $2.78 | $1.03 | $0.06 | $1.06 | — | $2.35 |
| 2009 | $3.75 | $1.41 | $0.12 | $1.53 | — | $3.54 |
| 2010 | $4.55 | $1.66 | $0.04 | $1.59 | — | $3.66 |
| 2011 | $5.31 | $1.77 | $0.08 | $2.22 | — | $4.47 |
| 2012 | $6.13 | $1.64 | $0.25 | $1.77 | — | $6.12 |
| 2013 | $6.61 | $1.81 | $0.08 | $1.75 | $0.00 | $7.41 |
| 2014 | $15.11 | $7.35 | $0.34 | $7.44 | $0.00 | $10.29 |
| 2015 | $21.46 | $11.91 | $0.49 | $13.48 | $1.29 | $13.03 |
| 2016 | $22.38 | $9.94 | $0.55 | $12.00 | $1.84 | $14.42 |
| 2017 | $19.79 | $3.51 | $0.45 | $8.57 | $2.08 | $15.63 |
| 2018 | $16.92 | $4.17 | $0.71 | $5.72 | $2.28 | $16.68 |
| 2019 | $17.58 | $4.22 | $0.65 | $6.51 | $2.52 | $17.79 |
| 2020 | $19.55 | $0.10 | $0.51 | $5.95 | $2.72 | $14.52 |
| 2021 | $21.64 | $4.93 | $0.46 | $8.56 | $2.84 | $16.80 |
| 2022 | $21.62 | $3.64 | $0.58 | $6.61 | $2.92 | $17.03 |
| 2023 | $21.55 | $4.50 | $0.47 | $5.90 | $3.00 | $18.32 |
| 2024 | $22.91 | $0.38 | $0.42 | $8.21 | $3.08 | $15.51 |
| 2025 | $23.46 | $6.78 | $0.45 | $7.53 | $3.16 | $18.29 |
Common questions about Gilead Sciences
How much does one share of Gilead Sciences earn?
Over the last 12 months, Gilead Sciences lost $2.60 for each share on $24.40 of sales.
Does Gilead Sciences pay a dividend?
Yes. Gilead Sciences paid $3.22 per share in dividends over the last 12 months, and it paid a dividend in every year from 2015 to 2025 in StockSlicer’s data.
What is Gilead Sciences’s book value per share?
Gilead Sciences’s book value is $9.53 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Gilead Sciences have?
Each share of Gilead Sciences has $2.56 of cash and investments and $21.15 of debt, as of June 30, 2026.
What is Gilead Sciences’s free cash flow per share?
$10.37 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
How has Gilead Sciences’s profit per share changed over time?
Profit per share went from $0.82 in 2007 to $6.78 in 2025, growing about 12.4% a year (adjusted for stock splits).
Has Gilead Sciences bought back shares?
Gilead Sciences’s share count fell about 35% from 2007 to 2025. Through buybacks, each remaining share owns a bigger slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.